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1  | INTRODUC TION
Why organisms’ age has been puzzling evolutionary biologists for 
decades (Kirkwood & Austad, 2000). Indeed, why should natural se‐
lection promote a decline in fitness? The solution to this apparent 
paradox was provided by Hamilton (1966) who demonstrated that 
the strength of selection weakens with age. The idea that selec‐
tion weakens with age is a shared assumption of most evolutionary 
theories of aging, including the antagonistic pleiotropy hypothesis. 
Williams (1957) suggested that genes impairing fitness at old age will 
be selected for if they have fitness‐enhancing roles at young age. 
Given that the intensity of selection is stronger during early life, the 
benefit of such pleiotropic genes will outweigh any late‐life cost. 
The antagonistic pleiotropy hypothesis has attracted considerable 
attention (Gaillard & Lemaitre, 2017), and indeed, individuals with 
better performance in early life usually age faster than individuals 
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Abstract
Aging is associated with a decline of performance leading to reduced reproductive 
output and survival. While the antagonistic pleiotropy theory of aging has attracted 
considerable attention, the molecular/physiological functions underlying the early‐
life benefits/late‐life costs paradigm remain elusive. We tested the hypothesis that 
while early activation of the inflammatory response confers benefits in terms of pro‐
tection against infection, it also incurs costs in terms of reduced reproductive output 
at old age and shortened longevity. We infected mice with the malaria parasite 
Plasmodium yoelii and increased the inflammatory response using an anti‐IL‐10 recep‐
tor antibody treatment. We quantified the benefits and costs of the inflammatory 
response during the acute phase of the infection and at old age. In agreement with 
the antagonistic pleiotropy hypothesis, the inflammatory response provided an 
early‐life benefit, since infected mice that were treated with anti‐IL‐10 receptor anti‐
bodies had reduced parasite density and anemia. However, at old age, mice in all 
treatment groups had similar levels of C‐reactive protein, reproductive output, sur‐
vival rate, and lifespan. Overall, our results do not support the hypothesis that the 
benefits of a robust response to malaria infection in early life incur longer term fit‐
ness costs.
K E Y W O R D S
antagonistic pleiotropy, inflammation, Plasmodium yoelii, senescence, survival
2  |     LIPPENS Et aL.
with poor early performance [see Lemaitre et al. (2015) for a recent 
review]. The mechanisms underlying these antagonistic pleiotropy 
effects	remain,	however,	poorly	understood.	Particularly	challenging	
issues with the study of the antagonistic pleiotropy hypothesis are 
(a) the identification of genes with antagonistic pleiotropic functions; 
(b) the assessment of the early‐life fitness benefits; and (c) uncover‐
ing the physiological pathways linking early‐life benefits to late‐life 
costs. An extension of the antagonistic pleiotropy hypothesis, at the 
phenotypic level, was subsequently proposed (Kirkwood, 1977) and 
coined the disposable soma hypothesis (Kirkwood & Holliday, 1979). 
The idea is that energy or resources (sensu lato) required to avoid 
or repair defective cellular machinery (i.e., the maintenance of the 
somatic line) become unavailable for reproduction, finally resulting 
in a trade‐off between reproduction and survival.
The inflammatory response is an excellent candidate function 
with antagonistic properties across lifespan. Inflammation is an 
essential component of the antimicrobial defense and response 
to trauma (Medzhitov, 2008). Animal models with knocked‐out 
genes of the inflammatory response have poor survival prospects 
during	 infection	 [see,	 for	 instance,	 Kurtz,	 Foreman,	 Bosio,	 Anver,	
and	Elkins	(2013),	and	Sorci,	Lippens,	Léchenault,	and	Faivre	(2017)	
for a synthesis]. Inflammation is, however, a nonspecific defense 
that can also damage host tissues, and many age‐associated dis‐
eases have an inflammatory origin (including cancer and cardio‐
vascular	 diseases)	 (Reverri,	 Morrissey,	 Cross,	 &	 Steinberg,	 2014;	
Wu, Antony, Meitzler, & Doroshow, 2014). Chronic inflammation is 
actually a disease status of old age that has been coined “inflam‐
maging” (Candore, Caruso, & Colonna‐Romano, 2010; Vasto et al., 
2007). Therefore, while the inflammatory response certainly con‐
fers a benefit in terms of immune protection, it can also generate 
life‐threatening diseases at old age.
In	a	seminal	paper,	Finch	and	Crimmins	(2004)	analyzed	the	age‐
specific	mortality	 rate	 of	 human	 cohorts	 in	 preindustrial	 Sweden.	
They showed that high infant mortality (presumably due to infec‐
tious diseases in times with rudimental medical care) was associated 
with high old‐age mortality in the same cohorts. They suggested 
this “cohort morbidity phenotype” reflects the late negative con‐
sequences of chronic inflammation elicited by persistent exposure 
to pathogenic organisms starting from an early age. However, sub‐
sequent studies in other human populations have found no or neg‐
ative associations, between early‐ and late‐life mortality (Barbi & 
Vaupel, 2005; Gagnon & Mazan, 2009; Hayward, Rigby, & Lummaa, 
2016). Given the correlative nature of historical human data and the 
potential for confounding effects, it is not surprising that demo‐
graphic analyses of human cohorts have provided such mixed re‐
sults	(Bengtsson	&	Broström,	2009;	Bengtsson	&	Lindström,	2003;	
Catalano & Bruckner, 2006; Myrskylä, 2010).
Experimental approaches are needed to test the role of inflam‐
mation as a function with antagonistic properties, potentially accel‐
erating	aging	(Khan,	Agashe,	&	Rolff,	2017;	Pursall	&	Rolff,	2011).	
We quantified the early‐life benefits and late‐life costs of the in‐
flammatory response using the malaria parasite Plasmodium yoelii 
and its rodent host. P. yoelii induces an inflammatory response that 
is followed by antibody production (Bakir, Tomiyama, & Abo, 2011; 
Chen et al., 2010; Couper, Blount, & Riley, 2008; Couper, Blount, 
Wilson, et al., 2008). We infected young mice and augmented the 
inflammatory response of one group by administering an anti‐IL‐10 
receptor antibody. IL‐10 is one of the principal anti‐inflammatory cy‐
tokines that contributes to the regulation of the immune response 
and the resolution of inflammation (Ouyang, Rutz, Crellin, Valdez, 
& Hymowitz, 2011). Blocking IL‐10, either at the phenotypic level 
(with antibodies) or at the genetic level (in knocked‐out models), 
results in overproduction of pro‐inflammatory mediators and a re‐
duction in parasite density (improved resistance) (Couper, Blount, & 
Riley,	2008;	Redpath,	Fonseca,	&	Perona‐Wright,	2014).	We	subse‐
quently drug‐cured all mice, after the acute phase of infection, and 
compared their longevity and reproductive success at old age rela‐
tive to that of several control groups. If the inflammatory response 
elicited by P. yoelii infection has antagonistic pleiotropic functions, 
we	 made	 two	 predictions.	 First,	 anti‐IL‐10R‐treated	 mice	 should	
better resist the infection than mice only infected with P. yoelii. 
Second,	P. yoelii‐infected mice (and particularly those also treated 
with the anti‐IL‐10R antibody) should have lower reproductive out‐
put at old age and reduced longevity compared to uninfected con‐
trol mice.
2  | MATERIAL S AND METHODS
2.1 | Animals and infections
Sixty	female	BALB/cJRj	mice	were	purchased	(Janvier	Labs),	housed	
(six	 individuals	 per	 cage—18.5	×	38	×	22.5	cm—enriched	with	 shel‐
ters), maintained under a constant temperature (24°C) and a pho‐
toperiod of 12:12 (L:D), and given ad libitum filtered water and food 
(standard mouse pellets).
At 7 weeks of age, mice were allocated to one out of five dif‐
ferent groups (n = 12 mice per group). Two groups of mice were 
infected with 105 red blood cells infected with Plasmodium yoelii 
17XNL by intraperitoneal injection of 100 µl of citrate saline‐diluted 
blood. One of the groups also received a treatment with an anti‐IL‐10 
receptor antibody (intraperitoneal injection of 20 µg of monoclonal 
anti‐IL‐10R	antibodies;	1B1.3a;	BD	PharMingen).	These	mice	were	
treated four times, one day prior to Plasmodium infection, and at 
day	1,	3,	and	5	postinfection.	The	dose	of	anti‐IL‐10R	was	chosen	
based on pilot experiments aimed at checking that the treatment did 
effectively upregulate the inflammatory response without inducing 
acute lethal immunopathology (Long, Chan, Allen, Read, & Graham, 
2008). Control groups of uninfected mice received an intraperito‐
neal injection with 106 heat‐killed P. yoelii‐infected red blood cells, 
or an intraperitoneal injection of anti‐IL‐10R antibodies at the same 
dose during four nonconsecutive days, or were left unmanipulated. 
At	day	39	postinfection,	all	mice	were	given	7	mg/ml	Pyrimethamine	
(VetranalTM	‐	Sigma	Aldrich)	in	their	drinking	water	for	five	consec‐
utive	 days	 to	 clear	 the	 infection	 (Staszewski,	 Reece,	O’Donnell,	&	
Cunningham, 2012).
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2.2 | Early‐life parameters
During the acute phase of the infection, we assessed parasite den‐
sity	at	days	3,	5,	7,	10,	12,	14,	17,	20,	24,	27,	and	31	postinfection.	
Parasite	density	was	also	assessed	at	day	55	postinfection	to	make	
sure that the antimalarial treatment was effective in clearing the 
infection.	Five	microliters	of	blood	were	collected	from	the	tail	tip,	
diluted in 200 µl of citrate saline (8.5 g NaCl; 15 g citrate sodium 
in 1 L of distilled water), and centrifuged at 17,000 g	for	3	min	at	
4°C. The supernatant was then removed and the pellet frozen at 
−80°C.	Parasite	density	was	assessed	by	real‐time	PCR	on	StepOne	
Real‐Time	PCR	System	of	Life	Technologies.	DNA	extraction	was	
performed	with	the	MAGMAX	DNA	Multi‐Sample	Kit	(Ambion	by	
Life Technologies) following the protocol provided by the manu‐
facturer	with	3	µl	of	blood	diluted	in	75	µl	of	eluent.	The	amplified	
gene was P. yoelii merozoite	surface	protein	4/5	gene	(PyMSP4/5)	
using	an	Applied	Biosystems	StepOne	Plus	thermocycler	(Applied	
Biosystems by Life Technologies). A probe was used for fluores‐
cence	signal.	For	each	sample	and	gene,	three	replicates	were	car‐
ried out in a total volume of 20 µl reaction, which included 12.5 µl 
TaqMan®	Universal	PCR	Master	Mix	(Applied	Biosystems),	0.75	µl	
of each primer (10 µM), 2 µl of extracted DNA, 5 µl of probe 
(10	µM),	and	3.5	µl	of	RNAse/DNase‐free	water	to	complete	the	
total	volume.	The	PCR	amplification	was	as	follows:	a	first	step	at	
50°C for 2 min to activate the probe followed by a denaturation 
step	at	95°C	for	10	min,	 then	40	PCR	cycles	 including	denatura‐
tion and annealing step at 95°C for 15 s and elongation at 60°C 
for 1 min. To prove the specificity of the assay, melting curves for 
all reactions were determined. This procedure consisted of incu‐
bations for 15 s at 95°C, 60 s at 60°C, and a final slow heating 
with	a	rate	of	0.3°C	per	second	up	to	95°C	with	continuous	fluo‐
rescence measurement. A negative control (water) was added on 
each plate to ensure the absence of any contamination. A real‐
time	PCR	standard	was	made	using	blood	from	one	 individual	at	
the peak of the acute phase (day 12 postinfection). A blood smear 
was made in the morning when parasites are in the ring stage, and 
parasites counted under optical microscopy (×10,000 red blood 
cells). We also assessed the number of red blood cells per µl of 
blood, which allowed us to estimate the number of parasites per µl 
of blood. This standard blood was serially diluted to have a range 
of	parasite	doses	and	use	them	as	standards	in	the	real‐time	PCR.	
Crossing point values (Cp) were estimated for each sample using 
the	second	derivative	maximum	method	implemented	in	StepOne	
software	 (Thermo	 Fisher	 scientific,	 Waltham,	 MA,	 USA).	 Mean	
Cp values of three replicates were used. The number of parasites 
per µl of blood was calculated by linear interpolation using the 
regression between the log10 number of parasites per µl in the 
standard and the associated Cp. The detection threshold was be‐
tween	5	and	50	parasites	per	µl	of	blood.	PyMSP4/5	primers	used	
were	 5’‐ATCCATCTACTAGTTTGAATCAAAATGA‐3’	 for	 the	 for‐
ward	 primer	 and	 5’‐CCATTTAGTTTATCTGATTTGTTTGTATTT‐3’	
for the reverse primer (94pb). The probe sequence was 
5’‐6FAM‐TCATAATTCAAACCCAGATGC‐MGB‐3’.
We counted red and white blood cells at days 0, 5, 7, 10, 12, 14, 
17,	20,	24,	27,	and	31	postinfection.	Two	microliters	of	blood	were	
collected	from	the	tail	tip,	diluted	in	18	µl	of	PBS,	and	stored	on	ice	
before measurement. Red and white blood cells were counted using 
a	SCIL	Vet	abc	Plus+	hematology	analyzer.
At	day	3	postinfection,	we	also	assessed	three	cytokines	 (IL‐6,	
IL‐10,	IFN‐γ) and one chemokine (CXCL10) as markers of the inflam‐
matory response in the blood. We collected ca. 100 µl of blood from 
the maxillary vein, using a sterile lancet needle. Blood was imme‐
diately centrifuged at 4°C and 4,000 g	 for	10	min.	Plasma	was	 im‐
mediately	stored	at	−80°C.	We	used	the	Luminex	technology	on	a	
Bio‐plex200	 instrument	 (Biorad®,	 USA)	 to	 assess	 the	 concentra‐
tion	 of	 IL‐6,	 IL‐10,	 IFN‐	 γ, and CXCL10, with a Milliplex® Map kit 
(MCYTOMAG‐70 K, Millipore, Germany). A total of 25 µl of plasma 
was used, following the manufacturer’s kit instructions.
2.3 | Late‐life parameters
We assessed C‐reactive protein in plasma of mice at the age of 469 
and 795 days, as a marker of chronic inflammation. We collected ca. 
100 µl of blood from the maxillary vein, using a sterile lancet needle. 
Blood was immediately centrifuged at 4°C and 4,000 g for 10 min, 
and	plasma	 immediately	 stored	 at	 −80°C.	We	used	 the	Mouse	C‐
Reactive	 Protein/CRP	 Quantikine	 ELISA	 Kit	 (MCRP00)	 of	 Bio‐
Techne®	to	assess	the	concentration	of	CRP.	Plasma	samples	were	
diluted	by	2,000,	and	the	ELISA	assay	was	conducted	following	the	
manufacturer’s kit instructions. Each sample was run in duplicate, 
and the mean values were used in the statistical analyses.
When females were 487 days old [far past the age of reproduc‐
tive	peak	 (Silver,	1995)],	 they	were	placed	 in	 individual	cages	with	
a male (we used a different male for each female) for 10 days. We 
defined reproductive success as the probability to breed and litter 
size at birth. When this first reproductive bout was completed, males 
were replaced in the females’ cages (we kept the same female–male 
pair) and the procedure repeated for three reproductive bouts. 
Females	were	613	days	old	at	the	end	of	the	third	reproductive	bout.
Mice were monitored every other day to check their health sta‐
tus and survival. Mice that reached the endpoint (Organization 
for Economic Cooperation & Development, 2000) were humanely 
euthanized.
2.4 | Statistical analyses
We used general linear mixed‐effect models to test the effect of 
experimental treatments on parasite density, red blood cell, and 
leukocyte counts (log‐transformed) over the course of the acute 
infection	(PROC	MIXED,	SAS).	Models	included	time	postinfection,	
squared time, and experimental group as fixed factors (plus interac‐
tions), and mouse identity as a random factor. Degrees of freedom 
were	approximated	using	 the	Satterthwaite	method.	Although	 the	
general linear mixed‐effect model indicated that the two infected 
groups had different parasite densities (F1,222 = 9.15, p = 0.0028), 
the model poorly fitted the data and using different distributions of 
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errors or data transformation did not improve the fit. We therefore 
used	a	nonparametric	test	(Wilcoxon	two‐sample	exact	test;	PROC	
NPAR1WAY,	SAS)	to	compare	cumulative	parasite	density	per	indi‐
vidual	(the	sum	of	parasite	density	up	to	day	31	p.i.)	between	the	two	
P. yoelii‐infected groups. Two individuals were removed from this 
analysis because they died during the acute phase of the infection 
(one in the P. yoelii group and one in the P. yoelii	+	anti‐IL‐10R	group).
Differences between experimental groups in cytokines in plasma 
at	day	3	postinfection	and	C‐reactive	protein	level	at	the	age	of	469	
and	 795	days	 were	 analyzed	 using	 a	 Kruskal–Wallis	 test	 (PROC	
NPAR1WAY,	SAS).
The probability to breed at old age was analyzed using a generalized 
linear	mixed‐effect	model	with	a	binomial	distribution	of	errors	(PROC	
GLIMMIX,	SAS).	Reproductive	bout	and	experimental	group	(plus	the	
two‐way interaction) were included as fixed factors and mouse iden‐
tity as a random factor. Litter size was analyzed using a generalized 
linear	mixed‐effect	model	with	a	Poisson	distribution	of	errors	(PROC	
GLIMMIX,	SAS).	This	model	included	the	same	fixed	and	random	terms	
of the previous one. We also tested whether the overall probability to 
breed and the cumulative litter size over the three reproductive bouts 
(the sum of litter size per individual) differed among experimental 
groups,	using	a	Fisher’s	exact	test	(PROC	FREQ,	SAS)	and	a	generalized	
linear	model	with	a	Poisson	distribution	of	errors	 (PROC	GENMOD,	
SAS),	respectively.	Overdispersion	was	corrected	in	this	last	model	by	
scaling the deviance (deviance/df	=	1);	 using	 a	 zero‐inflated	 Poisson	
distribution	 of	 errors	 provided	 the	 same	 results.	 Finally,	 we	 used	 a	
generalized	linear	model	with	a	Poisson	distribution	of	errors	(PROC	
GENMOD,	SAS),	and	scaled	deviance,	to	investigate	whether	cumula‐
tive litter size of females that did breed (therefore excluding those with 
zero cumulative litter size) differed among experimental groups.
Differences in age‐dependent mortality and lifespan among exper‐
imental	groups	were	analyzed	with	a	log‐rank	test	(PROC	LIFETEST,	
SAS)	and	a	one‐way	ANOVA	(PROC	GLM,	SAS),	respectively.
3  | RESULTS
3.1 | Acute infection
Infection with Plasmodium yoelii is expected to upregulate the in‐
flammatory response during the acute phase. In line with this ex‐
pectation,	we	 found	 that	 the	 cytokines	 IL‐6,	 IL‐10,	 IFN‐γ, and the 
chemokine CXCL10 were upregulated in P. yoelii‐infected mice, and 
especially so in infected mice that also received the anti‐IL‐10R treat‐
ment (Kruskal–Wallis: IL‐6, 휒2 = 27.01, p < 0.0001; IL‐10, 휒2	=	34.56,	
p	<	0.0001;	 IFN‐γ, 휒2	=	33.61,	 p < 0.0001; CXCL10, 휒2 = 24.72, 
p < 0.0001; n	=	55;	Figure	1).	Similarly,	we	found	that	Plasmodium‐in‐
fected mice had a sharp rise in leukocyte counts at day 10 and 12 p.i. 
compared	to	the	uninfected	groups	(Figure	2,	Table	1).
Parasite	density	peaked	at	day	12	postinfection	for	both	groups	
of	infected	mice	(Figure	3a).	Cumulative	parasite	density	was	lower	
in the P. yoelii	+	anti‐IL‐10R	group	(Wilcoxon	two‐sample	exact	test,	
p	=	0.0041,	Figure	3b),	this	result	being	particularly	driven	by	differ‐
ences at days 5 (Wilcoxon two‐sample exact test, p	=	0.0423)	and	7	
postinfection (Wilcoxon two‐sample exact test, p = 0.0014). At day 
55,	after	the	Pyrimethamine	treatment,	none	of	the	mice	had	detect‐
able parasites.
All infected mice became anemic, with minimum red blood cell 
values	 reached	at	day	12	and	14	postinfection	 (Figure	4,	Table	2).	
However, treating mice with the anti‐IL‐10R antibody reduced ane‐
mia	of	infected	mice	(Figure	4,	Table	3).	All	infected	mice	had	recov‐
ered by day 80 p.i., exhibiting similar red blood cell densities to the 
uninfected control groups [means ± SE (×106/mm3), unmanipulated: 
8.81 ± 0.16; anti‐IL‐10R: 8.59 ± 0.15; dead P. yoelii: 8.75 ± 0.12; P. yo-
elii: 9.08 ± 0.14; P. yoelii	+	anti‐IL‐10R:	9.02	±	0.25;	one‐way	ANOVA:	
F4,53	=	1.36,	p = 0.2595].
F I G U R E  1   IL‐6,	IL‐10,	IFN‐γ, CXCL10 concentration (pg/ml) in 
plasma of mice in the different experimental groups (means ± SE)
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3.2 | Carryover effects
We investigated whether early infection and an enhanced inflam‐
matory response had carryover effects in terms of chronic in‐
flammation	 by	 assessing	CRP	 in	 plasma	when	mice	were	 469	 and	
795 days old. Mice in the different experimental groups had similar 
CRP	values,	both	at	the	age	of	469	days	and	at	the	age	of	795	days	
(age = 469 days: Kruskal–Wallis 휒2 = 2.08, p = 0.721; age = 795 days: 
Kruskal–Wallis 휒2 = 7.26, p	=	0.123;	 Supporting	 Information	
Appendix	S1:	Figure	S1).
Reproductive success at old age was assessed as the probability 
to breed and as litter size over three reproductive bouts. Although 
many females did not breed at all because of their advanced age, the 
probability to breed significantly decreased over the three repro‐
ductive bouts (Table 4), but the rate of decrease was similar for the 
different experimental groups (nonsignificant interaction between 
reproductive bout and treatment, Table 4). When using litter size as 
a measure of reproductive success, the results were similar: Litter 
size decreased over time but at a similar rate for the different exper‐
imental	groups	(Supporting	Information	Appendix	S1:	Table	S1).	The	
comparison of the overall probability to breed and the cumulative 
litter size (sum of the litter size over the three reproductive bouts) 
confirmed that there were no differences among the experimental 
groups	 (Fisher’s	 exact	 test,	 p = 0.7928; generalized linear model, 
휒
2 = 7.77, p	=	0.1003,	n	=	52;	Figure	5).	Finally,	we	compared	cumu‐
lative litter size among experimental groups using only females that 
did reproduce. Again, this model showed that there were no differ‐
ences among groups (generalized linear model, 휒2 = 7.62, p = 0.1067, 
n = 20).
Lifespan did not differ among experimental groups (one‐way 
ANOVA: F4,51 = 0.44; p	=	0.7821).	Similarly,	the	analysis	of	time‐de‐
pendent mortality did not show any difference among groups (log‐
rank test: 휒2 = 2.98; p	=	0.5606;	Figure	6).
4  | DISCUSSION
The antagonistic pleiotropy is one of the most studied hypotheses to 
explain the evolution of aging. However, the vast majority of studies 
have focused on the trade‐off between early and late expressed fit‐
ness traits, neglecting the molecular and/or physiological functions 
underlying these trade‐offs (Lemaitre et al., 2015). Here, we provide 
the first experimental test of the antagonistic pleiotropy properties 
of the inflammatory response in a vertebrate species. Our aim was 
twofold: i) to assess the early benefits of the inflammatory response 
during the acute phase of a Plasmodium infection and ii) quantify 
the costs paid at late age. We found that infection does activate the 
inflammatory response and that mice with the strongest inflamma‐
tory response (P. yoelii	+	anti‐IL‐10R	group)	had	lower	parasite	den‐
sity. Mice in the P. yoelii	+	anti‐IL‐10R	group	were	also	 less	anemic	
compared to P. yoelii‐infected individuals. These results indicate, 
therefore, that inflammation in response to P. yoelii infection confers 
Sources of variation Estimate ± SE F df p
Time p.i. −0.041	±	0.014 5.98 1,575 0.0147
Squared	time	p.i. 0.001 ± 0.0004 35.88 1,574 <0.0001
Treatment
Unmanipulated 0.151 ± 0.150 4.90 4,513 0.0007
Anti‐IL−10R −0.062 ± 0.150
Dead  Plasmodium yoelii 0
P. yoelii −0.481 ± 0.151
P. yoelii	+	anti‐IL‐10R −0.161 ± 0.150
Time p.i. × Treatment
Unmanipulated −0.036	±	0.020 49.68 4,575 <0.0001
Anti‐IL−10R −0.016 ± 0.020
Dead P. yoelii 0
P. yoelii 0.182 ± 0.021
P. yoelii	+	anti‐IL‐10R 0.153 ± 0.021
Squared	time	p.i.	×	Treatment
Unmanipulated 0.001 ± 0.001 63.24 4,574 <0.0001
Anti‐IL−10R 0.0003 ± 0.001
Dead P. yoelii 0
P. yoelii −0.006 ± 0.001
P. yoelii	+anti‐IL‐10R −0.006 ± 0.001
Random factor z
Mouse identity 0.013 ± 0.006 2.29 0.011
TA B L E  1   General linear mixed‐effect 
model exploring the effect of time 
postinfection, squared time postinfection, 
and experimental groups on changes in 
white blood cell count (log‐transformed) 
during the acute phase of the infection (up 
to	day	31	postinfection)
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benefits. They also corroborate previous findings showing that 
IL‐10 plays a crucial role in regulating the immune response against 
Plasmodium and therefore in host resistance and pathology (Couper, 
Blount,	&	Riley,	2008;	Couper,	Blount,	Wilson,	et	al.,	2008;	Freitas	
do Rosario & Langhorne, 2012). However, we did not find support 
for the assumption that early‐life inflammation incurs late‐life costs. 
CRP,	 late	 reproductive	 success,	 age‐dependent	mortality,	 and	 lon‐
gevity were similar among infected and uninfected controls.
Our assessment of the benefits of the inflammatory response 
was restricted to two proxies of the cost of infection: parasite den‐
sity and anemia. We used a nonlethal strain (17XNL) of P. yoelii be‐
cause we did not want to induce any mortality during the acute phase 
of the infection, and therefore, we could not directly compare the 
survival of mice in the different experimental groups. Nevertheless, 
there is extensive evidence showing that parasite density and ane‐
mia are good predictors of Plasmodium‐induced mortality (see, for 
instance,	Laroque	et	al.,	2012;	Mackinnon	&	Read,	2004;	Perkins	et	
al., 2011). Keeping parasite proliferation under control and limiting 
the loss of red blood cells can therefore be seen as good proxies of 
the likelihood to survive the infection and therefore of early fitness 
(including reproductive success). Moreover, recent work has shown 
a direct link between the suppression of pro‐inflammatory cytokines 
in knockout (KO) mouse models and the probability to die during an 
infection, due to the substantial increase in parasite burden in KO 
compared	to	wild‐type	individuals	(Sorci	et	al.,	2017).
The idea that early exposure to infectious agents that stimulate 
the inflammatory response has negative carryover effects at late age 
rests on the assumption that previously infected individuals have a 
chronic pro‐inflammatory phenotype, which makes them more vul‐
nerable to a range of diseases. Evidence for such an association be‐
tween early acute and late chronic inflammation is, however, mixed. 
For	 instance,	 high	 exposure	 to	microbial	 infection	 in	 a	 human	 co‐
hort	in	the	Philippines	correlated	with	lower	C‐reactive	protein	level	
during adulthood (McDade, Rutherford, Adair, & Kuzawa, 2010), and 
a Ghanaian cohort living in a malaria endemic area had inherently 
similar	CRP	levels	to	a	Dutch	cohort	(Eriksson,	van	Bodegom,	May,	
Boef,	&	Westendorp,	2013).	There	are	also	many	reports	suggesting	
that early exposure to microbes might have an “educational” role for 
the immune system by stimulating regulatory mechanisms that pre‐
vent autoimmune damage (Rook, 2009). In line with these results, 
we did not find evidence that Plasmodium‐infected mice had upreg‐
ulated	CRP	levels	at	old	age.
In	 addition	 to	 having	 similar	 CRP	 levels,	 mice	 in	 the	 different	
experimental groups also had similar fitness components, assessed 
as reproductive success at old age and age‐dependent mortality. 
Reproductive success was very low for the whole sample of mice 
[litter	size	of	BALB/c	mice	at	prime	age	being	around	5	pups;	Silver	
(1995)], showing that they were in a status of reproductive senes‐
cence. In inbred mouse strains, such as BALB/c, female fecundity is 
greatly	reduced	by	the	age	of	10	months	(Silver,	1995),	and	indeed,	
we found that many females did not breed at all. Nevertheless, the 
probability to breed and litter size decreased over the three repro‐
ductive bouts, albeit the rate of decrease was similar for the dif‐
ferent experimental groups. Mean longevity ranged from 752 days 
for mice that were exposed to dead P. yoelii to	 831	days	 for	mice	
that were infected with the parasite, and did not significantly differ 
among	groups.	Further,	that	infected	mice	lived	on	average	46	days	
F I G U R E  3   (a)	Parasite	density	(×106/µl) over the course of the 
acute phase of the infection for the two Plasmodium yoelii‐infected 
groups (means ± SE). (b) Cumulative parasite density (sum up to day 
31	p.i.)	for	the	two	P. yoelii‐infected groups (means ± SE)
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longer than noninfected mice suggests we did not make a type 2 
error due to lack of statistical power. These results, therefore, show 
that infected mice aged at a similar pace, whatever the treatment 
they were exposed to when young.
Our study focused on females, and we cannot exclude that 
males might be more prone to pay late costs of early infection. 
Sex‐related	 differences	 in	 immune	 function	 and	 parasite	 resis‐
tance	have	been	reported	in	several	studies	(see	Klein,	&	Flanagan,	
2016 for a review), and therefore, an interesting extension of the 
current work would be to test for sex‐specific aging in response 
to early infection and inflammation. Running an experiment with 
both males and females might further provide the opportunity to 
explore the role played by other physiological pathways with po‐
tentially antagonistic functions through lifespan, such as sexual 
hormones.
Although the hypothesis that early activation of the inflamma‐
tory response might increase late‐occurring mortality was put for‐
ward	by	Finch	and	Crimmins	(2004)	based	on	the	analysis	of	human	
Sources of variation Estimate ± SE F df p
Time p.i. 0.171 ± 0.045 30.46 1,575 <0.0001
Squared	time	p.i. −0.004	±	0.001 64.54 1,574 <0.0001
Treatment
Unmanipulated 0.916 ± 0.467 2.48 4,514 0.0432
Anti‐IL‐10R 0.697 ± 0.469
Dead  Plasmodium yoelii 0
P. yoelii 0.061 ± 0.470
P. yoelii	+	anti‐IL‐10R −0.340	±	0.468
Time p.i. × Treatment
Unmanipulated −0.135	±	0.063 40.67 4,575 <0.0001
Anti‐IL‐10R −0.098 ± 0.063
Dead P. yoelii 0
P. yoelii −0.664 ± 0.064
P. yoelii	+	anti‐IL‐10R −0.516 ± 0.064
Squared	time	p.i.	×	Treatment
Unmanipulated 0.003	±	0.002 54.16 4,574 <0.0001
Anti‐IL‐10R 0.002 ± 0.002
Dead P. yoelii 0
P. yoelii 0.023 ± 0.002
P. yoelii	+	anti‐IL‐10R 0.017 ± 0.002
Random factor z
Mouse identity 0.126 ± 0.056 2.25 0.0122
TA B L E  2   General linear mixed‐effect 
model exploring the effect of time 
postinfection, squared time postinfection, 
and experimental groups on changes in 
red blood cell count during the acute 
phase	of	the	infection	(up	to	day	31	
postinfection)
Sources of variation Estimate ± SE F df p
Time p.i. −0.346	±	0.047 161.24 1,222 <0.0001
Squared	time	p.i. 0.013	±	0.001 246.92 1,220 <0.0001
Treatment
P. yoelii 0.390 ± 0.520 0.56 1,135 0.4541
P. yoelii	+	anti‐IL‐10R 0
Time p.i. × Treatment
P. yoelii −0.150 ± 0.066 5.12 1,222 0.0247
P. yoelii	+	anti‐IL‐10R 0
Squared	time	p.i.	×	Treatment
P. yoelii 0.005 ± 0.002 6.82 1,220 0.0096
P. yoelii	+	anti‐IL‐10R 0
Random factor z
Mouse identity 0.364	±	0.170 2.14 0.0160
TA B L E  3   General linear mixed‐effect 
model exploring the effect of time 
postinfection, squared time postinfection, 
and experimental groups on changes in 
red blood cell count during the acute 
phase	of	the	infection	(up	to	day	31	
postinfection). Only the two infected 
groups (Plasmodium yoelii and 
P. yoelii	+	anti‐IL‐10R)	were	considered	
here
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cohort mortalities, subsequent studies failed to support the hypoth‐
esis. In particular, a recent study showed that exposure to infectious 
diseases in early life does not predict late‐life mortality in a prein‐
dustrial	 population	 in	 Finland	 (Hayward	 et	 al.,	 2016).	 Our	 experi‐
mental results provide further support to the idea that exposure to 
infectious diseases in early life does not necessarily accelerate the 
rate of senescence. However, it should be fully acknowledged that 
our experimental approach only involved a punctual early infection 
that was readily cleared by the antimalarial treatment, and animals 
subsequently faced a pathogen‐free environment. Arguably, this is 
very different from a natural situation where hosts are repeatedly 
exposed to infectious threats with a persistent activation of the in‐
flammatory machinery. Therefore, the lack of long‐term fitness cost 
of early infection might be due to our choice to induce a short, acute, 
inflammatory response whereas a more persistent chronic inflam‐
matory	 status	might	be	 required	 to	 incur	 late	 costs.	 Further	work	
should definitely explore how timing and persistence of an early pro‐
inflammatory status affects late‐life fitness traits.
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